On March 25, 2011
Internal J&J Emails Detail “Ugly” Chapter in Mismarketing of Antipsychotics
The emails give us a rare glimpse into the backbiting that happens inside drug companies when they fall afoul of the FDA.
No tags for this post.
0 Comments